LifeStance (LFST) Extends 4-Day Run on Strong Earnings

We recently published 10 Stocks With Whopping 11-97% Upside. LifeStance Health Group, Inc. (NASDAQ:LFST) is one of the best-performing stocks on Wednesday.

LifeStance Health extended its winning streak to a fourth straight day on Wednesday, jumping 10.94 percent to close at $5.17 apiece after reporting a strong performance in the second quarter of the year.

Based on its updated report, net loss narrowed by 84 percent to $3.8 million from $23.3 million in the same period last year. Revenues increased by 11 percent to $345.3 million from $312.3 million year-on-year on the back of a higher visit volume from net clinician growth.

Clinician base ended at 7,708 during the period, an increase of 173 or 11 percent from the first quarter of the year.

“I am incredibly proud of the LifeStance team for the strong results achieved in the second quarter,” said LifeStance Health Group, Inc. (NASDAQ:LFST) CEO Dave Bourdon, underscoring the double-digit organic revenue growth and 10 percent adjusted EBITDA margin.

Encouraged by the results, LifeStance Health Group, Inc. (NASDAQ:LFST) maintained its full-year revenue growth target of $1.4 billion to $1.44 billion, as well as adjusted EBITDA to $140 million to $150 million.

For the third quarter of the year, total revenues were expected to grow between $345 million and $365 million, while adjusted EBITDA was pegged at $33 million to $39 million.

While we acknowledge the potential of LFST as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.